THE ROLE OF PLANTS IN THE TREATMENT OF DISEASES CAUSED BY MICRO-ORGANISMS BASED IN THE NATURAL PRODUCTS

CHAPTER ONE: INTRODUCTION

1.1 Background of Study

Plants have been used as medicines for thousands of years across all human civilizations, forming the foundation of traditional medicine systems such as Ayurveda (India), Traditional Chinese Medicine (TCM), Unani (Greco-Arabic), and African traditional medicine (WHO, 2019). Before the advent of modern antibiotics and synthetic drugs, plant-based remedies were the primary means of treating infectious diseases caused by bacteria, fungi, viruses, and parasites (Cragg and Newman, 2020). Even today, an estimated 80% of the population in developing countries relies on traditional plant-based medicines for their primary healthcare needs, due to affordability, accessibility, and cultural acceptance (Farnsworth, 2019). In Nigeria, traditional medicine practitioners use hundreds of plant species to treat various ailments, including microbial infections, malaria, respiratory infections, diarrheal diseases, skin infections, and wound infections (Sofowora, 2021).

Natural products derived from plants are chemical compounds produced by plants as secondary metabolites, which are not directly involved in growth, development, or reproduction but serve ecological functions such as defense against herbivores, pathogens (micro-organisms), and competing plants (Croteau, Kutchan, and Lewis, 2018). These secondary metabolites include alkaloids, terpenoids, flavonoids, phenolics, tannins, saponins, glycosides, coumarins, and essential oils, among others (Dewick, 2019). Many of these compounds have been shown to possess antimicrobial, antifungal, antiviral, antiparasitic, anti-inflammatory, and antioxidant properties, making them valuable candidates for the development of new antimicrobial agents (Newman and Cragg, 2020). The World Health Organization (WHO) has recognized the importance of traditional medicine and natural products in primary healthcare, and has encouraged member states to integrate traditional medicine into national health systems (WHO, 2019).

Diseases caused by micro-organisms (bacteria, fungi, viruses, and parasites) remain a major global health challenge, particularly in developing countries where infectious diseases account for a high proportion of morbidity and mortality (WHO, 2022). Bacterial infections such as pneumonia, tuberculosis, typhoid fever, cholera, urinary tract infections, wound infections, and sepsis kill millions annually (GBD, 2020). Fungal infections such as candidiasis, aspergillosis, dermatophytosis (ringworm, athlete’s foot), and systemic fungal infections are increasingly common, especially among immunocompromised patients (HIV/AIDS, cancer chemotherapy, organ transplant recipients) (Brown et al., 2020). Viral infections such as influenza, HIV/AIDS, hepatitis, herpes, and emerging viruses (Ebola, COVID-19) continue to pose significant threats (WHO, 2022). Parasitic infections such as malaria (caused by Plasmodium species), trypanosomiasis (sleeping sickness), leishmaniasis, amoebiasis, and helminth infections affect hundreds of millions, particularly in tropical regions (GBD, 2020).

The emergence and spread of antimicrobial resistance (AMR) has become one of the most urgent global health crises of the 21st century (WHO, 2022). Many pathogenic bacteria have developed resistance to multiple antibiotics: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae, carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Mycobacterium tuberculosis (MDR-TB) (CDC, 2021). Antifungal resistance is also emerging: azole-resistant Candida and Aspergillus species are increasingly reported (Brown et al., 2020). Antiviral resistance has been documented for HIV, influenza, and herpes viruses (WHO, 2022). Antimalarial resistance to chloroquine, sulfadoxine-pyrimethamine, and more recently artemisinin derivatives (artemisinin resistance in Southeast Asia) threatens malaria control efforts (World Malaria Report, 2021).

The crisis of antimicrobial resistance has renewed interest in natural products from plants as sources of new antimicrobial agents (Newman and Cragg, 2020). Plants produce a vast diversity of chemical compounds (estimated 200,000-500,000 secondary metabolites) with diverse biological activities (Croteau et al., 2018). Historically, many important antibiotics and antimalarials were derived from natural products: penicillin (from the fungus Penicillium), tetracycline (from Streptomyces bacteria), quinine (from cinchona bark), artemisinin (from Artemisia annua), and doxorubicin (from Streptomyces) (Cragg and Newman, 2020). Modern drug discovery continues to explore plant natural products as leads for new antimicrobial agents, particularly those with novel mechanisms of action that could overcome existing resistance (Newman and Cragg, 2020).

The major classes of plant secondary metabolites with antimicrobial activity include (Dewick, 2019; Sofowora, 2021):

Alkaloids: Nitrogen-containing compounds such as berberine (from Berberis, Hydrastis), quinine (from Cinchona), artemisinin (from Artemisia annua – though technically a sesquiterpene lactone), and caffeine. Alkaloids can intercalate into DNA, inhibit protein synthesis, or disrupt cell membranes.

Terpenoids (Terpenes): Volatile compounds such as menthol, thymol, carvacrol (from essential oils of thyme, oregano, mint), and artemisinin. Terpenoids disrupt microbial cell membranes, inhibit electron transport, and interfere with cell wall synthesis.

Flavonoids: Phenolic compounds such as quercetin, kaempferol, apigenin, and catechins (from green tea). Flavonoids inhibit bacterial enzymes, disrupt cell membranes, and have antioxidant and anti-inflammatory effects.

Tannins: Polymeric phenolic compounds found in many plants (e.g., Terminalia, Acacia, Camellia). Tannins bind to microbial proteins and enzymes, inhibit cell wall synthesis, and have astringent properties.

Phenolics and phenolic acids: Gallic acid, ellagic acid, caffeic acid, ferulic acid (from fruits, vegetables, herbs). Phenolics disrupt microbial cell membranes and inhibit enzyme activity.

Saponins: Glycosidic compounds with soap-like properties found in Quillaja, Glycyrrhiza (licorice), and Panax (ginseng). Saponins disrupt cell membranes and have immunomodulatory effects.

Glycosides: Compounds with a sugar moiety attached to a non-sugar aglycone, such as cardiac glycosides (digitalis) and cyanogenic glycosides. Some glycosides have antimicrobial activity.

Essential oils: Complex mixtures of terpenoids and phenolics from aromatic plants (thyme, oregano, clove, tea tree, eucalyptus, lemongrass). Essential oils have broad-spectrum antimicrobial activity, disrupting cell membranes and inhibiting enzyme systems.

Medicinal plants used in Nigerian traditional medicine for treating microbial infections include (Sofowora, 2021; Okafor and Nwosu, 2020):

Plant Species	Common Name	Part Used	Traditional Use	Reported Activity
Azadirachta indica	Neem	Leaves, bark	Malaria, skin infections, wound healing	Antibacterial, antifungal, antimalarial
Vernonia amygdalina	Bitter leaf	Leaves	Malaria, fever, gastrointestinal infections	Antimalarial, antibacterial
Ocimum gratissimum	Scent leaf	Leaves	Cough, diarrhea, skin infections, oral hygiene	Antibacterial, antifungal
Allium sativum	Garlic	Bulbs	Infections, hypertension, cardiovascular	Antibacterial, antifungal, antiviral
Zingiber officinale	Ginger	Rhizomes	Respiratory infections, nausea, inflammation	Antibacterial, antifungal, antiviral
Aloe vera	Aloe	Leaf gel	Wound healing, skin infections, burns	Antibacterial, antifungal, wound healing
Carica papaya	Pawpaw	Leaves, seeds	Malaria, digestive infections, wound healing	Antimalarial, antibacterial
Cymbopogon citratus	Lemongrass	Leaves	Fever, infections, malaria	Antibacterial, antifungal
Terminalia catappa	Indian almond	Leaves, bark	Skin infections, wound healing	Antibacterial, antifungal
Jatropha curcas	Physic nut	Leaves, latex	Wound healing, skin infections	Antibacterial

The mechanisms by which plant natural products exert antimicrobial effects include (Cowan, 2019; Sofowora, 2021):

Mechanism	Description	Example Compounds
Cell membrane disruption	Compounds insert into microbial membranes, increasing permeability, causing leakage of cellular contents	Terpenoids (thymol, carvacrol), saponins, essential oils
Cell wall synthesis inhibition	Prevent formation of peptidoglycan or chitin in bacterial or fungal cell walls	Tannins, some flavonoids
Protein synthesis inhibition	Bind to bacterial ribosomes (70S) or fungal ribosomes (80S), preventing protein production	Alkaloids (berberine)
Nucleic acid synthesis inhibition	Intercalate into DNA or inhibit DNA gyrase, preventing replication	Alkaloids (quinine, berberine), flavonoids
Enzyme inhibition	Inhibit key microbial enzymes (e.g., dihydrofolate reductase, DNA polymerase, protease)	Tannins, flavonoids, phenolics
Efflux pump inhibition	Block bacterial efflux pumps, which pump antibiotics out of the cell, reversing resistance	Some flavonoids (e.g., epicatechin gallate)
Quorum sensing inhibition	Disrupt bacterial communication systems that regulate virulence factor production	Some essential oil components

The advantages of plant-derived antimicrobials over synthetic antibiotics include (Newman and Cragg, 2020; Sofowora, 2021): Multiple mechanisms of action – Plant extracts often contain multiple compounds that act on multiple microbial targets simultaneously, making it more difficult for microbes to develop resistance (combination effect). Novel chemistry – Plant secondary metabolites have chemical structures not found in synthetic antibiotic classes, potentially overcoming existing resistance. Traditional knowledge – Centuries of traditional use provide information on safety, efficacy, and dosing. Availability and affordability – Medicinal plants are often locally available and affordable for rural populations. Lower toxicity – Many medicinal plants have low toxicity when used traditionally, though some can be toxic (requiring proper dosing).

Challenges in the use of plant natural products for treating infectious diseases include (WHO, 2019; Sofowora, 2021): Standardization – Plant extracts vary in chemical composition depending on plant species, variety, growing conditions, harvest time, processing, and storage. Quality control – Lack of quality control standards for traditional medicines. Dosage determination – Optimal therapeutic doses are often not scientifically determined. Limited clinical evidence – Few plant natural products have been rigorously tested in randomized controlled trials. Regulatory hurdles – Traditional medicines are regulated differently from synthetic drugs; registration requires evidence of safety, efficacy, and quality. Adulteration and contamination – Traditional medicines may be adulterated with synthetic drugs or contaminated with heavy metals, microbes, or toxins.

From a theoretical perspective, this study is supported by three theories: Chemotaxonomy Theory (Hegnauer, 1963), which proposes that the distribution of chemical compounds (secondary metabolites) in plants follows taxonomic relationships (plants within the same family produce similar compounds with similar activities); Ethnopharmacology Theory (Farnsworth, 2019), which uses traditional knowledge as a guide for drug discovery (plants used traditionally for microbial infections are more likely to contain antimicrobial compounds than randomly selected plants); and Phytochemical Diversity Theory (Wink, 2018), which posits that plants produce a vast diversity of secondary metabolites as a defense strategy, and this chemical diversity provides a rich source of novel antimicrobial agents.

In summary, plants have played a crucial role in the treatment of diseases caused by micro-organisms throughout human history, and natural products from plants continue to be important sources of antimicrobial agents. The emergence of antimicrobial resistance has renewed interest in plant natural products as sources of new antibiotics, antifungals, and antivirals. Nigerian medicinal plants have been used traditionally to treat various infections, but many have not been scientifically validated. This study aims to review the role of plants in the treatment of diseases caused by micro-organisms, based on natural products, with a focus on the mechanisms of action, major bioactive compounds, and the potential for development of new antimicrobial agents.

1.2 Statement of Problems

The emergence and spread of antimicrobial resistance (AMR) among pathogenic bacteria, fungi, viruses, and parasites has become a global health crisis, rendering many existing synthetic antimicrobial drugs ineffective. Multidrug-resistant organisms (MDROs) such as MRSA, VRE, ESBL-producing Enterobacteriaceae, CRE, MDR-TB, and azole-resistant Candida are increasingly common, leading to higher morbidity, mortality, and healthcare costs. At the same time, the pipeline of new antimicrobial drugs from synthetic chemistry has slowed dramatically, with few new classes of antibiotics developed in the past three decades. Natural products from plants, which have historically provided important antimicrobial agents (quinine, artemisinin, berberine), remain an underexplored source of new antimicrobial compounds. Many medicinal plants used traditionally in Nigeria to treat microbial infections have not been scientifically evaluated for their antimicrobial activity, mechanisms of action, or safety. There is limited documentation of the specific plant species, plant parts, extraction methods, and active compounds used. The role of plants in the treatment of diseases caused by micro-organisms needs to be systematically reviewed and evaluated to identify promising candidates for antimicrobial drug development. The problem this study addresses is the need to comprehensively review and evaluate the role of plants in the treatment of diseases caused by micro-organisms, based on natural products, focusing on the major classes of bioactive compounds, their mechanisms of action, and the evidence for their antimicrobial efficacy.

1.3 Aim of the Study

The specific aim of this research work is to review and evaluate the role of plants in the treatment of diseases caused by micro-organisms, based on natural products, with a view to identifying major classes of plant secondary metabolites with antimicrobial activity, elucidating their mechanisms of action, documenting medicinal plants used in Nigerian traditional medicine for microbial infections, and assessing the potential for development of new antimicrobial agents from plant natural products.

1.4 Objectives of the Study

1. To identify the major classes of plant secondary metabolites (alkaloids, terpenoids, flavonoids, tannins, phenolics, saponins, glycosides, essential oils) with documented antimicrobial activity.
2. To describe the mechanisms of action by which plant natural products exert antimicrobial effects (cell membrane disruption, cell wall inhibition, protein synthesis inhibition, nucleic acid inhibition, enzyme inhibition, efflux pump inhibition, quorum sensing inhibition).
3. To document medicinal plants used in Nigerian traditional medicine for the treatment of bacterial, fungal, viral, and parasitic infections.
4. To evaluate the scientific evidence (in vitro, in vivo, clinical studies) for the antimicrobial efficacy of selected medicinal plants.
5. To assess the potential and challenges for developing new antimicrobial agents from plant natural products in the context of antimicrobial resistance.

1.5 Research Questions

1. What are the major classes of plant secondary metabolites (alkaloids, terpenoids, flavonoids, tannins, phenolics, saponins, glycosides, essential oils) with documented antimicrobial activity?
2. What are the mechanisms of action by which plant natural products exert antimicrobial effects against bacteria, fungi, viruses, and parasites?
3. What medicinal plants are used in Nigerian traditional medicine for the treatment of bacterial, fungal, viral, and parasitic infections?
4. What is the scientific evidence (in vitro, in vivo, clinical studies) for the antimicrobial efficacy of selected medicinal plants used in Nigeria?
5. What are the potentials and challenges for developing new antimicrobial agents from plant natural products in the context of antimicrobial resistance?

1.6 Research Hypotheses

Hypothesis One

• H₀ (Null): Plant secondary metabolites do not possess significant antimicrobial activity against pathogenic micro-organisms.
• H₁ (Alternative): Plant secondary metabolites possess significant antimicrobial activity against pathogenic micro-organisms.

Hypothesis Two

• H₀ (Null): There is no significant relationship between plant chemotaxonomy and antimicrobial activity (plants in the same family do not share antimicrobial compounds).
• H₁ (Alternative): There is a significant relationship between plant chemotaxonomy and antimicrobial activity.

Hypothesis Three

• H₀ (Null): Traditional use of medicinal plants for treating microbial infections is not correlated with scientifically demonstrated antimicrobial activity.
• H₁ (Alternative): Traditional use of medicinal plants for treating microbial infections is correlated with scientifically demonstrated antimicrobial activity.

Hypothesis Four

• H₀ (Null): Plant natural products do not have novel mechanisms of action that could overcome existing antimicrobial resistance.
• H₁ (Alternative): Plant natural products have novel mechanisms of action that could overcome existing antimicrobial resistance.

Hypothesis Five

• H₀ (Null): Plant natural products cannot be developed into clinically useful antimicrobial agents due to challenges in standardization, dosage, and clinical evidence.
• H₁ (Alternative): Plant natural products can be developed into clinically useful antimicrobial agents despite challenges.

1.7 Justification of the Study

This study is justified on several grounds. First, the global crisis of antimicrobial resistance requires urgent discovery of new antimicrobial agents with novel mechanisms of action. Plant natural products represent a rich, underexplored source of chemical diversity. Second, Nigeria has a rich tradition of medicinal plant use for treating infections, but many plants have not been scientifically validated. Documenting and evaluating these plants could lead to discovery of new antimicrobial compounds. Third, understanding the mechanisms of action of plant antimicrobials can inform rational drug design and identify compounds that overcome resistance. Fourth, the study will contribute to the growing field of ethnopharmacology, which uses traditional knowledge as a guide for drug discovery. Fifth, the findings will inform policy on traditional medicine integration into national health systems and support the development of phytomedicines as alternatives or complements to synthetic antibiotics.

1.8 Significance of the Study

The findings of this research will be significant to several stakeholders. To traditional medicine practitioners, the study will provide scientific validation of plant-based remedies for microbial infections, supporting their continued use and integration into healthcare. To pharmaceutical scientists and drug discovery researchers, the study will identify promising plant species, bioactive compounds, and mechanisms of action for development of new antimicrobial agents. To healthcare practitioners (doctors, pharmacists, nurses) , the study will provide evidence on plant-based alternatives for treating infections, particularly in resource-limited settings. To policymakers (Federal Ministry of Health, NAFDAC, WHO) , the findings will inform policies on traditional medicine integration, regulation of herbal medicines, and support for natural product research. To patients and the general public, the study will promote awareness of the role of plants in treating infections and support the rational use of herbal remedies. To academic researchers, the study will contribute to the literature on ethnopharmacology, phytochemistry, and antimicrobial drug discovery.

1.9 Scope of the Scope

The scope of this study is delimited to the role of plants in the treatment of diseases caused by micro-organisms, based on natural products. The study focuses on major classes of plant secondary metabolites (alkaloids, terpenoids, flavonoids, tannins, phenolics, saponins, glycosides, essential oils) with documented antimicrobial activity. The study covers mechanisms of action: cell membrane disruption, cell wall synthesis inhibition, protein synthesis inhibition, nucleic acid synthesis inhibition, enzyme inhibition, efflux pump inhibition, and quorum sensing inhibition. The study covers target micro-organisms: bacteria (Gram-positive and Gram-negative), fungi (yeasts and molds), viruses (enveloped and non-enveloped), and parasites (protozoa and helminths). The study includes medicinal plants used in Nigerian traditional medicine (based on literature review and documented ethnobotanical studies). The study reviews scientific evidence from in vitro (laboratory), in vivo (animal), and clinical (human) studies. The study does not extend to plant-based treatments for non-infectious diseases (cancer, diabetes, hypertension, inflammation) except where relevant to antimicrobial mechanisms; does not include detailed phytochemical isolation and structure elucidation (only major classes); does not include clinical trial design or regulatory approval pathways (only review of existing evidence).

1.10 Definition of Terms

Natural Products: Chemical compounds produced by living organisms (plants, microbes, marine organisms) that are not essential for primary metabolic processes (growth, development, reproduction) but serve ecological functions (defense, signaling). Plant natural products are also called secondary metabolites.

Plant Secondary Metabolites: Chemical compounds produced by plants that are not directly involved in growth and development but play roles in defense against herbivores, pathogens, and competing plants. Major classes include alkaloids, terpenoids, flavonoids, tannins, phenolics, saponins, glycosides, and essential oils.

Antimicrobial Activity: The ability of a substance (synthetic or natural) to kill or inhibit the growth of micro-organisms, including bacteria (antibacterial), fungi (antifungal), viruses (antiviral), and parasites (antiparasitic).

Alkaloids: Nitrogen-containing secondary metabolites (e.g., berberine, quinine, caffeine) produced by plants. Many alkaloids have antimicrobial activity through DNA intercalation, protein synthesis inhibition, or membrane disruption.

Terpenoids (Terpenes): Diverse class of secondary metabolites built from isoprene units (C5H8). Examples include menthol, thymol, carvacrol, artemisinin. Many terpenoids have antimicrobial activity through membrane disruption and enzyme inhibition.

Flavonoids: Polyphenolic secondary metabolites (e.g., quercetin, kaempferol, catechins) with a C6-C3-C6 structure. Flavonoids have antimicrobial, antioxidant, and anti-inflammatory activities.

Tannins: Polymeric phenolic compounds that bind to and precipitate proteins. Tannins have astringent and antimicrobial properties, binding to microbial cell wall proteins and enzymes.

Phenolics (Phenolic Acids): Simple phenolic compounds (e.g., gallic acid, caffeic acid, ferulic acid) with antimicrobial, antioxidant, and anti-inflammatory activities.

Saponins: Glycosidic compounds with soap-like properties (form stable foam in water). Saponins have antimicrobial, immunomodulatory, and cholesterol-lowering activities.

Glycosides: Compounds consisting of a sugar moiety (glycone) attached to a non-sugar aglycone. Examples include cardiac glycosides (digitalis) and cyanogenic glycosides.

Essential Oils: Volatile, aromatic oils extracted from plants (distillation, expression). Complex mixtures of terpenoids, phenolics, and other volatile compounds. Essential oils (thyme, oregano, clove, tea tree, eucalyptus, lemongrass) have broad-spectrum antimicrobial activity.

Antimicrobial Resistance (AMR): The ability of a micro-organism (bacterium, fungus, virus, parasite) to grow in the presence of an antimicrobial drug that would normally kill it or inhibit its growth, due to genetic mutations or acquisition of resistance genes.

Minimum Inhibitory Concentration (MIC): The lowest concentration of an antimicrobial agent that visibly inhibits the growth of a micro-organism in vitro. Lower MIC indicates more potent activity.

Minimum Bactericidal Concentration (MBC): The lowest concentration of an antibacterial agent that kills 99.9% of the initial bacterial inoculum. MBC is higher than or equal to MIC.

Zone of Inhibition: The clear area (halo) around an antimicrobial disc on an agar plate where bacterial growth is inhibited; measured in millimeters (mm). Larger zones indicate greater susceptibility.

Chemotaxonomy: The classification of plants based on the distribution of chemical compounds (secondary metabolites). Plants within the same family often produce similar compounds with similar biological activities.

Ethnopharmacology: The scientific study of traditional medicines (plant, animal, mineral-based) used by different cultures, using pharmacological principles to validate traditional uses and discover new drugs.

Phytochemistry: The study of chemicals derived from plants, including secondary metabolites, their structures, biosynthesis, and biological activities.

Efflux Pump: A protein complex in the bacterial cell membrane that pumps antimicrobial drugs out of the cell, reducing intracellular drug concentration and conferring resistance. Some plant flavonoids inhibit efflux pumps, reversing resistance.

CHAPTER TWO: LITERATURE REVIEW

2.1 Conceptual Framework

The conceptual framework for this study is organized around the key concepts of plant natural products (secondary metabolites), the major classes of bioactive compounds, their mechanisms of antimicrobial action, target micro-organisms, and the pathway from traditional knowledge to drug development. These concepts are defined, operationalized, and related to one another below.

2.1.1 Concept of Plant Natural Products (Secondary Metabolites)

Plant natural products, also known as secondary metabolites, are chemical compounds produced by plants that are not directly involved in growth, development, or reproduction (primary metabolism) but serve ecological functions such as defense against herbivores, pathogens, and competing plants (Croteau, Kutchan, and Lewis, 2018). Plants produce an estimated 200,000-500,000 secondary metabolites, representing a vast diversity of chemical structures and biological activities (Wink, 2018).

Classification of Plant Secondary Metabolites:

Class	Basic Structure	Examples	Source Plants	Antimicrobial Activity
Alkaloids	Nitrogen-containing heterocyclic	Berberine, quinine, caffeine, morphine	Berberis, Cinchona, Coffea	DNA intercalation, protein synthesis inhibition
Terpenoids	Isoprene (C5H8) units	Thymol, carvacrol, menthol, artemisinin	Thymus, Origanum, Mentha, Artemisia	Membrane disruption, enzyme inhibition
Flavonoids	C6-C3-C6 (two aromatic rings)	Quercetin, kaempferol, catechins	Camellia, Allium, Citrus	Enzyme inhibition, membrane disruption
Tannins	Polymeric phenolics (hydrolyzable or condensed)	Gallotannins, ellagitannins, proanthocyanidins	Terminalia, Acacia, Camellia	Protein precipitation, enzyme inhibition
Phenolics	Simple phenolic ring	Gallic acid, caffeic acid, ferulic acid	Many plants	Membrane disruption, antioxidant
Saponins	Steroid or triterpene + sugar	Saponins (Quillaja), glycyrrhizin (licorice)	Quillaja, Glycyrrhiza, Panax	Membrane disruption, immunomodulation
Glycosides	Sugar + aglycone	Cardiac glycosides, cyanogenic glycosides	Digitalis, Prunus	Various mechanisms
Essential oils	Complex mixtures of terpenoids	Thyme oil, oregano oil, tea tree oil	Thymus, Origanum, Melaleuca	Membrane disruption, multifactorial

2.1.2 Mechanisms of Antimicrobial Action of Plant Natural Products

Plant natural products exert antimicrobial effects through multiple mechanisms, often acting on multiple microbial targets simultaneously (Cowan, 2019; Sofowora, 2021).

Mechanism 1: Cell Membrane Disruption

Description	Compounds penetrate and disrupt the microbial cell membrane, increasing permeability, causing leakage of cellular contents (ions, ATP, metabolites), and leading to cell death
Target Micro-organisms	Bacteria (both Gram-positive and Gram-negative), fungi, some viruses (enveloped)
Active Compounds	Terpenoids (thymol, carvacrol), essential oils, saponins, some flavonoids
Evidence	Increased membrane permeability (dye uptake), leakage of potassium ions, loss of membrane potential

Mechanism 2: Cell Wall Synthesis Inhibition

Description	Compounds interfere with the synthesis of peptidoglycan (bacteria) or chitin (fungi), leading to weakened cell walls, osmotic lysis, and cell death
Target Micro-organisms	Bacteria, fungi
Active Compounds	Tannins, some flavonoids
Evidence	Inhibition of peptidoglycan synthesis enzymes (e.g., transpeptidase), increased sensitivity to osmotic shock

Mechanism 3: Protein Synthesis Inhibition

Description	Compounds bind to bacterial ribosomes (70S) or fungal ribosomes (80S), preventing translation and protein production
Target Micro-organisms	Bacteria, fungi
Active Compounds	Alkaloids (berberine), some flavonoids
Evidence	Inhibition of protein synthesis measured by radioactive amino acid incorporation

Mechanism 4: Nucleic Acid Synthesis Inhibition

Description	Compounds intercalate into DNA (between base pairs) or inhibit DNA gyrase/topoisomerase, preventing DNA replication and transcription
Target Micro-organisms	Bacteria, viruses, parasites
Active Compounds	Alkaloids (quinine, berberine), some flavonoids
Evidence	DNA intercalation (increased viscosity, altered UV spectrum), inhibition of DNA polymerase or gyrase

Mechanism 5: Enzyme Inhibition

Description	Compounds inhibit key microbial enzymes (e.g., dihydrofolate reductase, protease, reverse transcriptase), disrupting metabolic pathways
Target Micro-organisms	Bacteria, viruses (HIV), parasites
Active Compounds	Tannins, flavonoids, phenolics
Evidence	Enzyme activity assays (e.g., reduction in enzyme activity with increasing inhibitor concentration)

Mechanism 6: Efflux Pump Inhibition

Description	Compounds inhibit bacterial efflux pumps (e.g., NorA, TetK), which normally pump antibiotics out of the cell, thereby reversing resistance and increasing intracellular antibiotic concentration
Target Micro-organisms	Bacteria (especially multidrug-resistant strains)
Active Compounds	Some flavonoids (e.g., epicatechin gallate, 5′-methoxyhydnocarpin)
Evidence	Reduced efflux of fluorescent dyes (e.g., ethidium bromide), increased intracellular accumulation of antibiotics

Mechanism 7: Quorum Sensing Inhibition

Description	Compounds disrupt bacterial quorum sensing (cell-to-cell communication systems that regulate virulence factor production), reducing pathogenicity without killing the bacteria
Target Micro-organisms	Bacteria (e.g., Pseudomonas aeruginosa, Staphylococcus aureus)
Active Compounds	Some essential oil components (e.g., furanones), certain flavonoids
Evidence	Reduced production of quorum sensing-regulated virulence factors (e.g., pyocyanin, proteases, biofilms)

2.1.3 Target Micro-Organisms and Diseases

Plant natural products have been shown to be active against a wide range of pathogenic micro-organisms (WHO, 2022; GBD, 2020).

Bacterial Infections:

Bacteria	Disease	Gram Stain	Example Active Plant Compounds
Staphylococcus aureus (including MRSA)	Skin infections, pneumonia, sepsis, wound infections	Positive	Thymol, carvacrol, berberine
Escherichia coli	Urinary tract infections, diarrhea, sepsis	Negative	Quercetin, tannins
Pseudomonas aeruginosa	Wound infections, pneumonia (cystic fibrosis)	Negative	Carvacrol, thymol, essential oils
Mycobacterium tuberculosis	Tuberculosis (TB)	Acid-fast	Alkaloids, terpenoids
Salmonella typhi	Typhoid fever	Negative	Berberine, flavonoids
Vibrio cholerae	Cholera	Negative	Tannins, alkaloids
Helicobacter pylori	Gastric ulcers, gastritis	Negative	Flavonoids, terpenoids
Streptococcus pyogenes	Pharyngitis (strep throat), skin infections	Positive	Thymol, essential oils

Fungal Infections:

Fungus	Disease	Type	Example Active Plant Compounds
Candida albicans	Candidiasis (thrush, vaginitis, systemic)	Yeast	Terpenoids, essential oils, alkaloids
Aspergillus fumigatus	Aspergillosis (lung infection)	Mold	Terpenoids, essential oils
Trichophyton rubrum	Dermatophytosis (ringworm, athlete’s foot)	Dermatophyte	Terpenoids, essential oils
Cryptococcus neoformans	Cryptococcosis (meningitis in immunocompromised)	Yeast	Alkaloids, terpenoids
Malassezia furfur	Pityriasis versicolor (skin discoloration)	Yeast	Essential oils, terpenoids

Viral Infections:

Virus	Disease	Type	Example Active Plant Compounds
Influenza virus	Flu (influenza)	Enveloped RNA	Flavonoids, essential oils, alkaloids
Herpes simplex virus (HSV)	Cold sores, genital herpes	Enveloped DNA	Flavonoids, terpenoids, tannins
HIV	AIDS	Enveloped RNA	Alkaloids, flavonoids, terpenoids
Hepatitis B/C virus	Hepatitis	Enveloped DNA/RNA	Alkaloids, flavonoids
SARS-CoV-2 (COVID-19)	COVID-19	Enveloped RNA	Flavonoids, terpenoids, essential oils

Parasitic Infections:

Parasite	Disease	Type	Example Active Plant Compounds
Plasmodium falciparum	Malaria (cerebral, severe)	Protozoan	Quinine, artemisinin, alkaloids
Trypanosoma brucei	African sleeping sickness	Protozoan	Alkaloids, terpenoids
Leishmania species	Leishmaniasis	Protozoan	Alkaloids, terpenoids
Entamoeba histolytica	Amoebic dysentery	Protozoan	Tannins, alkaloids
Giardia lamblia	Giardiasis	Protozoan	Tannins, alkaloids
Ascaris lumbricoides	Roundworm infection	Helminth	Tannins, alkaloids

2.1.4 Traditional Knowledge to Drug Development Pathway

The pathway from traditional knowledge of medicinal plants to the development of new antimicrobial drugs involves multiple stages (Farnsworth, 2019; Newman and Cragg, 2020):

Stage	Description	Methods
1. Ethnobotanical survey	Document plants used traditionally for microbial infections	Interviews with traditional healers, literature review
2. Plant collection and identification	Collect plant specimens, voucher specimens for herbarium	Taxonomic identification
3. Extraction	Prepare crude extracts (water, ethanol, methanol, hexane, etc.)	Maceration, Soxhlet extraction, infusion, decoction
4. Phytochemical screening	Identify presence of alkaloids, terpenoids, flavonoids, tannins, saponins	Color tests, TLC, HPLC
5. In vitro antimicrobial testing	Test crude extracts against microbial strains	Disc diffusion, broth microdilution (MIC, MBC)
6. Bioassay-guided fractionation	Isolate active compounds by monitoring activity	Column chromatography, TLC, HPLC, LC-MS
7. Structure elucidation	Determine chemical structure of active compounds	NMR, MS, IR, UV
8. In vivo testing	Test active compounds in animal models	Mouse models of infection
9. Mechanism of action studies	Determine how compounds kill microbes	Enzyme assays, membrane permeability, DNA intercalation
10. Preclinical development	Toxicity, pharmacokinetics, formulation	Animal toxicology, ADME
11. Clinical trials	Test safety and efficacy in humans	Phase I, II, III clinical trials
12. Regulatory approval	Approval for medical use	NAFDAC (Nigeria), FDA (USA), EMA (Europe)

2.1.5 Conceptual Framework Diagram (Described in Text)

The conceptual framework can be visualized as follows:

Plant Natural Products → Mechanisms of Action → Target Micro-organisms → Clinical Application

Independent Variable: Plant Natural Products (Secondary Metabolites):

• Alkaloids, Terpenoids, Flavonoids, Tannins, Phenolics, Saponins, Glycosides, Essential oils

↓ Mechanisms of Action:

• Cell membrane disruption
• Cell wall synthesis inhibition
• Protein synthesis inhibition
• Nucleic acid synthesis inhibition
• Enzyme inhibition
• Efflux pump inhibition
• Quorum sensing inhibition

↓ Target Micro-organisms:

• Bacteria (Gram-positive, Gram-negative, acid-fast)
• Fungi (yeasts, molds, dermatophytes)
• Viruses (enveloped, non-enveloped)
• Parasites (protozoa, helminths)

↓ Clinical Application (Diseases):

• Bacterial diseases (tuberculosis, typhoid, cholera, UTI, wound infections)
• Fungal diseases (candidiasis, aspergillosis, ringworm)
• Viral diseases (influenza, herpes, HIV, COVID-19)
• Parasitic diseases (malaria, sleeping sickness, leishmaniasis, amoebiasis)

Traditional Knowledge → Drug Development Pathway:

• Ethnobotanical survey → Extraction → Phytochemical screening → In vitro testing → Bioassay-guided fractionation → Structure elucidation → In vivo testing → Clinical trials

The framework posits that plant natural products (secondary metabolites) exert antimicrobial effects through multiple mechanisms of action. These mechanisms target specific microbial structures and processes, leading to killing or inhibition of bacteria, fungi, viruses, and parasites. Traditional knowledge guides the selection of plants for study, and a systematic drug development pathway leads from crude extracts to purified active compounds to clinical application.

2.2 Theoretical Framework

This study is anchored on three supporting theories that provide a comprehensive theoretical foundation for understanding the role of plants in treating microbial diseases. These theories are Chemotaxonomy Theory, Ethnopharmacology Theory, and Phytochemical Diversity Theory.

2.2.1 Chemotaxonomy Theory

Chemotaxonomy Theory, developed by Hegnauer (1963) and refined by subsequent researchers, proposes that the distribution of chemical compounds (secondary metabolites) in plants follows taxonomic relationships (Hegnauer, 1963; Wink, 2018).

Core Propositions (Hegnauer, 1963):

1. Chemical characters are heritable: The ability to produce specific secondary metabolites is genetically determined and can be used as a taxonomic character, similar to morphological characters (flower, leaf, fruit).
2. Plants within the same family produce similar compounds: Plants belonging to the same family (e.g., Solanaceae, Asteraceae, Fabaceae, Lamiaceae, Apiaceae) often produce similar classes of secondary metabolites with similar biological activities.
3. Chemotaxonomic markers: Specific compounds can serve as chemotaxonomic markers for certain taxa. For example, tropane alkaloids (hyoscyamine, scopolamine) are characteristic of Solanaceae (nightshade family); iridoids are characteristic of Rubiaceae (coffee family); betalains are characteristic of Caryophyllales.
4. Evolutionary significance: The distribution of secondary metabolites has evolutionary significance; related plants share metabolic pathways, while distantly related plants have divergent chemistry.

Application to Antimicrobial Plant Natural Products

Chemotaxonomy Theory predicts (Hegnauer, 1963; Wink, 2018):

Plant Family	Characteristic Compounds	Antimicrobial Activity	Example Plants
Lamiaceae (mint family)	Terpenoids (thymol, carvacrol, menthol, rosmarinic acid)	Strong antibacterial, antifungal	Thymus (thyme), Origanum (oregano), Mentha (mint), Rosmarinus (rosemary)
Asteraceae (daisy family)	Sesquiterpene lactones (artemisinin), flavonoids	Antimalarial, antibacterial	Artemisia annua (sweet wormwood), Echinacea
Apiaceae (carrot family)	Essential oils (carvone, limonene), coumarins	Antibacterial, antifungal	Carum carvi (caraway), Coriandrum (coriander)
Fabaceae (legume family)	Flavonoids, tannins, isoflavonoids	Antibacterial, antifungal	Glycyrrhiza (licorice), Acacia
Rubiaceae (coffee family)	Alkaloids (quinine, quinidine, caffeine)	Antimalarial (quinine)	Cinchona officinalis (cinchona), Coffea
Solanaceae (nightshade family)	Tropane alkaloids, steroidal alkaloids	Antibacterial, antifungal	Atropa belladonna, Datura
Zingiberaceae (ginger family)	Terpenoids, phenolics (gingerol, curcumin)	Antibacterial, antifungal, antiviral	Zingiber officinale (ginger), Curcuma longa (turmeric)

Limitations: Chemotaxonomy is not absolute; there can be chemical variation within a family (some species produce compounds, others do not). Environmental factors (soil, climate, stress) also affect secondary metabolite production (Wink, 2018).

2.2.2 Ethnopharmacology Theory

Ethnopharmacology Theory, articulated by Farnsworth (2019) and other researchers, proposes that traditional knowledge (indigenous knowledge of medicinal plants) can be used as a guide for drug discovery (Farnsworth, 2019; Sofowora, 2021).

Core Propositions (Farnsworth, 2019):

1. Traditional knowledge is a validated screening tool: Plants used traditionally to treat a specific disease (e.g., malaria, diarrhea, wound infection) are significantly more likely to contain bioactive compounds than randomly selected plants. The “hit rate” for traditional plants is 80-90%, compared to 1-5% for random screening.
2. Ethnopharmacological approach is cost-effective: Using traditional knowledge to select plants for testing is much cheaper and faster than random screening of thousands of plant species.
3. Traditional use provides safety information: Generations of traditional use provide evidence of safety (or toxicity) that can guide drug development.
4. Cross-cultural validation: When the same plant (or plant family) is used to treat the same disease in different cultures (e.g., Artemisia annua for malaria in China, East Africa, and Europe), the evidence is stronger.

Evidence for Ethnopharmacology Theory:

Plant	Traditional Use	Disease	Modern Scientific Validation	Drug Developed
Cinchona officinalis	Bark used for fever (Peru, 17th century)	Malaria	Quinine isolated (1820); effective against Plasmodium	Quinine
Artemisia annua	Leaves used for fever (China, >2000 years)	Malaria	Artemisinin isolated (1972); effective against P. falciparum	Artemisinin (and derivatives)
Digitalis purpurea	Leaves used for dropsy (England, 18th century)	Heart failure	Digoxin isolated; increases cardiac contractility	Digoxin
Papaver somniferum	Latex used for pain (ancient Mesopotamia)	Pain	Morphine isolated (1805); analgesic	Morphine
Catharanthus roseus	Leaves used for diabetes (Madagascar)	Cancer (leukemia)	Vinblastine, vincristine isolated; antimitotic	Vinblastine, vincristine

Application to Nigerian Traditional Medicine

Ethnopharmacology Theory predicts (Sofowora, 2021; Okafor and Nwosu, 2020):

• Plants used traditionally in Nigeria to treat microbial infections (e.g., Azadirachta indica for malaria, Vernonia amygdalina for malaria/fever, Ocimum gratissimum for cough and diarrhea) should be prioritized for antimicrobial screening.
• These plants are likely to contain bioactive compounds with antimicrobial activity.
• Cross-cultural validation (same plant used in different Nigerian ethnic groups or different countries) strengthens evidence.

Limitations: Traditional knowledge can be incorrect (some traditional uses are not supported by science). Traditional knowledge may be lost as elders die and younger generations adopt Western medicine. Also, traditional knowledge is often not documented (oral tradition) (Farnsworth, 2019).

2.2.3 Phytochemical Diversity Theory

Phytochemical Diversity Theory, proposed by Wink (2018), posits that plants produce a vast diversity of secondary metabolites as a defense strategy against herbivores, pathogens, and competing plants, and this chemical diversity provides a rich source of novel bioactive compounds (Wink, 2018).

Core Propositions (Wink, 2018):

1. Defense hypothesis: Secondary metabolites evolved as defense compounds. Plants produce toxic, repellent, antimicrobial, antifungal, or antiviral compounds to deter herbivores, kill pathogens, and inhibit competing plants (allelopathy).
2. Chemical diversity is adaptive: The production of multiple, structurally diverse compounds (chemical cocktails) is more effective than a single compound because it targets multiple physiological systems, reduces the chance of resistance, and deters a wider range of herbivores and pathogens.
3. Plants are “chemical factories”: Each plant species produces a unique suite of secondary metabolites (chemical fingerprint). The estimated total number of plant secondary metabolites is 200,000-500,000, only a small fraction of which has been characterized.
4. Co-evolution: Plants and their pests (insects, microbes) have co-evolved for millions of years, leading to the evolution of new defense compounds and new resistance mechanisms. This co-evolutionary arms race has generated immense chemical diversity.

Implications for Antimicrobial Drug Discovery

Phytochemical Diversity Theory predicts (Wink, 2018; Newman and Cragg, 2020):

• Plant secondary metabolites are a rich, underexplored source of novel antimicrobial compounds with diverse mechanisms of action.
• Because plants have been producing these compounds for millions of years, microbes have been exposed to them for millions of years, but resistance is not universal because plants produce multiple compounds simultaneously (combination effect) and evolve new compounds.
• Plant compounds often have multiple mechanisms of action, reducing the likelihood that a single mutation will confer resistance.
• The vast chemical diversity of plants (>200,000 compounds) means that many novel antimicrobial agents remain to be discovered.

Estimates of Chemical Diversity:

Group	Number of Species	Estimated Secondary Metabolites per Species	Estimated Total
Flowering plants	~350,000	500-5,000	175 million – 1.75 billion (estimated)
Characterized	~50,000 (14%)	<100	<5 million
Fully characterized	~10,000 (3%)	<20	<200,000

(Source: Wink, 2018)

Limitations: Phytochemical diversity theory does not predict which plants or which compounds are likely to have antimicrobial activity; screening is still required. Also, many plant secondary metabolites are produced in very small quantities, making extraction and isolation challenging (Wink, 2018).

Integration of the Three Theories

The three theories are complementary and collectively provide a robust theoretical framework for this study:

Theory	Focus	Contribution to Study
Chemotaxonomy Theory	Distribution of compounds by plant family	Predicts which plant families are most promising (Lamiaceae, Asteraceae, Apiaceae, Fabaceae, Zingiberaceae)
Ethnopharmacology Theory	Traditional knowledge as guide for drug discovery	Predicts that plants used traditionally for infections will have antimicrobial activity
Phytochemical Diversity Theory	Diversity of secondary metabolites as chemical defense	Predicts that plants produce diverse, novel compounds with multiple mechanisms, overcoming resistance

Together, these theories support the study’s review of the role of plants in treating microbial diseases, recognizing that: (1) plant families predict chemistry (Chemotaxonomy); (2) traditional use predicts bioactivity (Ethnopharmacology); and (3) chemical diversity provides novel mechanisms (Phytochemical Diversity).

2.3 Review of Related Empirical Studies

This section reviews empirical studies relevant to the antimicrobial activity of plant natural products, organized by plant family, compound class, and mechanism of action.

2.3.1 Studies on Antimicrobial Activity of Lamiaceae (Mint Family)

Lamiaceae is one of the most studied plant families for antimicrobial activity (Cowan, 2019). Essential oils from Thymus vulgaris (thyme) and Origanum vulgare (oregano) are rich in thymol and carvacrol (60-80% of oil). MIC values for essential oils against S. aureus and E. coli range from 0.125-0.5 mg/mL. Terpenoids disrupt bacterial cell membranes, causing leakage of potassium ions and ATP, and inhibit efflux pumps (reversing resistance in MRSA). Thyme and oregano oils also inhibit Candida albicans (MIC 0.25-1.0 mg/mL) and Aspergillus niger (MIC 0.5-2.0 mg/mL).

Mentha piperita (peppermint) and Mentha spicata (spearmint) essential oils contain menthol, menthone, carvone, and limonene. MIC values range from 0.5-2.0 mg/mL against S. aureus, E. coli, and C. albicans. Peppermint oil has antiviral activity against herpes simplex virus (HSV-1) and influenza virus.

Rosmarinus officinalis (rosemary) essential oil (1,8-cineole, camphor, α-pinene) has MIC values 0.5-1.5 mg/mL against Bacillus cereus, S. aureus, E. coli, and C. albicans. Rosemary extracts also have antioxidant activity.

2.3.2 Studies on Antimicrobial Activity of Asteraceae (Daisy Family)

Artemisia annua (sweet wormwood) is the source of artemisinin, a sesquiterpene lactone effective against Plasmodium falciparum malaria (WHO, 2021). Artemisinin is effective against artemisinin-resistant strains (though resistance is emerging). Mechanism of action: artemisinin is activated by heme iron in the parasite, generating free radicals that alkylate and damage parasite proteins. Artemisia extracts also have antibacterial activity against S. aureus and E. coli.

2.3.3 Studies on Antimicrobial Activity of Zingiberaceae (Ginger Family)

Zingiber officinale (ginger) contains gingerols, shogaols, and terpenoids. MIC values range from 0.5-2.0 mg/mL against S. aureus, E. coli, Salmonella typhi, and C. albicans. Mechanism: membrane disruption, inhibition of efflux pumps, inhibition of biofilm formation. Ginger extract has antiviral activity against human respiratory syncytial virus (HRSV).

Curcuma longa (turmeric) contains curcumin (a polyphenol). MIC values range from 0.25-1.0 mg/mL against S. aureus, E. coli, Helicobacter pylori, and C. albicans. Curcumin has anti-inflammatory, antioxidant, and antimicrobial activities. Mechanism: membrane disruption, DNA intercalation, inhibition of bacterial virulence factors. Curcumin also inhibits efflux pumps, reversing antibiotic resistance in MRSA.

2.3.4 Studies on Antimicrobial Activity of Alkaloid-Containing Plants

Cinchona officinalis (cinchona) is the source of quinine and quinidine, alkaloids used for malaria for centuries. Quinine is effective against Plasmodium falciparum (MIC 0.1-1.0 μg/mL). Mechanism: quinine intercalates into parasite DNA, inhibiting DNA replication and transcription.

Berberis species (barberry) contain berberine, an isoquinoline alkaloid. MIC values range from 0.05-0.2 mg/mL against S. aureus, E. coli, Vibrio cholerae, Candida albicans, and Entamoeba histolytica. Mechanism: berberine intercalates into bacterial DNA, inhibits bacterial topoisomerase, and disrupts cell membranes.

2.3.5 Summary of Empirical Findings

The empirical literature reveals consistent findings: (1) Lamiaceae essential oils (thyme, oregano, peppermint, rosemary) have broad-spectrum antibacterial and antifungal activity; (2) terpenoids (thymol, carvacrol) are major active compounds, acting primarily by membrane disruption; (3) artemisinin from Artemisia annua is a highly effective antimalarial; (4) ginger and turmeric have antibacterial, antifungal, and antiviral activity; (5) alkaloids (quinine, berberine) act by DNA intercalation; (6) plant compounds often have multiple mechanisms of action; (7) plant extracts can reverse antibiotic resistance (efflux pump inhibition); (8) many plants used traditionally have been scientifically validated; (9) Nigerian medicinal plants (neem, bitter leaf, scent leaf, garlic, ginger) have documented antimicrobial activity. This review synthesizes these findings.

2.4 Summary of Literature Review

The table below summarizes key theoretical and empirical literature relevant to the role of plants in treating microbial diseases.

S/N	Author(s) and Year	Focus of Study	Strength	Weakness	Limitation	Gap Identified
1	Hegnauer (1963); Wink (2018)	Chemotaxonomy Theory	Predicts which plant families produce active